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The effects of monoclonal antibodies (mAbs) to cell-surface molecules, divalent cations,
and various cell-signaling and metabolic inhibitors on the binding of thymocytes to rat
thymic dendritic cells (TDC) were studied using a rosette assay. It was found that TDC/
thymocyte adhesion was stronger and faster at 37C than at 4C. Flow cytometric analysis
demonstrated that bound thymocytes were predominantly CD4/CD8 and CD4+CD8-, but
in comparison to the phenotype of whole thymocytes, they were enriched in the mature
TCR0
hi subset. The binding of thymocytes to TDC at 37C was almost completely
dependent on Ca2+ and Mg
2+ and partly on an intact cytoskeleton and calmodulin-
dependent protein kinase. The adhesion was independent of new protein synthesis and
the activities of protein kinasesAand C, tyrosine kinases, as well as phosphotyrosine protein
phosphatases. The TDC/thymocyte adhesion at 37C was partly blocked by anti-LFA-1
(WT.1), anti-CD18 (WT.3), and anti-ICAM-1 (1A29) mAb. MAbs to class IIMHC (OX-3 and
OX-6), CD4 (W3/25), CD8 (OX-8), and 0TCR (R73) stimulated the adhesion via an LFA-
1-dependent pathway, whereas an anti-CD45 mAb (G3C5) stimulated the rosette forma-
tion independently of LFA-1. MAbs to CD2 (OX-34), CD11b (ED7), CD11b/c (OX-42), and
class MHC (OX-18) were without significant effects on the adhesion process.
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INTRODUCTION
Thymic dendritic cells (TDC) represent minor,
but functionally very significant component of
the thymic microenvironment (Hamblin and
Edgeworth, 1988). They are derived from the bone
marrow and selectively colonize cortico-medullary
region and medulla (Barclay and Mayrhofer, 1981;
Duijvestijn et al., 1984; Kampinga and Aspinal
1990). TDC are believed to participate in the
maturational process of thymocyte development
(Kyewski, 1988), intrathymic presentation of non-
major histocompatibility complex (non-MHC) anti-
gens (Kyewski et al., 1986), clonal deletion of
autoreactive thymocytes (Carlow et al., 1992),
or clonal amplification of mature medullary
thymocytes (Landry et al., 1990). However, how they
influence these intrathymic events is still being
debated.
Corresponding author.
Enzyme digestion of thymic stroma enables isola-
tion of different complexes composed of non-
lymphoid cells and thymocytes (Kyewski et al.,
1982). TDC are also rosette-forming cells (Kyewski
et al., 1982; Landry et al., 1990; Shortman and Vremec,
1991). It is postulated that these close cell-cell con-
tacts are responsible for most of TDC functions
(Adkins et al., 1986; Kyewski, 1988). Although in-
teractions between peripheral dendritic cells (DC)
and T lymphocytes have been extensively explored,
little is known about the mechanisms involved in
TDC/thymocyte binding. This question is addressed
in the present work using an original system for
isolation of rat TDC.
RESULTS
Dynamics of Thymocyte Adhesion to Rat TDC
To study adhesion characteristics of rat TDC, we first
used an alternative method for their isolation and
3738 MIODRAGOLI and VESNA ILI
purification (Ilid et al., in press). This included isola-
tion of low-density cells from thymocyte suspension
over a Nycodenz gradient (density 1.078 g/cm3;
osmolarity 390 mOsm) and their subsequent culti-
vation with 20% TE-R 2.5 + HT supernatant obtained
by cocultivation of a medullary epithelial cell line
(TE-R 2.5) (olid et al., 1992) and hydrocortisone-
resistant thymocytes. This procedure allowed the re-
covery of TDC of relative high purity (more than
80%), their differentiation and expression of most
markers characteristic for rat TDC in situ, such as
MHC class I and class II molecules, CD45, CD25,
LFA-1 (CD11a/CD18), ICAM-1 (CD54), and OX-44
(CD53). Certain TDC subsets expressed CD11b and
thymocyte markers Thyl, CD2, CD4, and CD8. These
cells were functionally very active in inducing strong
proliferation of autologous thymocytes depleted of
endogenous accessory cells even without any addi-
tional stimuli (Ilid et al., in press).
Such prepared TDC were incubated with syn-
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FIGURE 1. Dynamics of rosette formation between TDC and thymocytes. TDC were mixed with thymocytes (ratio 1:20) and
incubated in Terasaki plates (hanging drop assay) for different periods of time both at 37 or 4C. The percentages of TDC-forming
rosettes from one of three similar experiments are given.THYMIC DENDRITIC CELL/THYMOCYTE ADHESION 39
geneicAO rat thymocytes (ratio 1:20) both at 37 and
4C using a hanging-drop assay in Terasaki plates.
After different periods of time, the percentage of
TDC-forming rosettes were calculated. The results
presented in Fig. 1 show that most TDC-formed
rosettes with thymocytes at 37C. The binding was
very strong because mostly large cell clusters were
observed (Fig. 2). The adhesion process was also very
fast reaching the maximum as early as after 30 min
of cell incubation and slightly decreased thereafter
(up to 5 hr). In contrast, the initial binding (30 min)
at 4C was very low. After that, it progressively in-
creased (up to 3 hr) reaching almost the same values
as those observed at 37C (Fig. 1).
Phenotypic Characteristics of Thymocytes
Bound to TDC
We next tested the phenotype of thymocytes bound
to TDC by flow cytometry. Purification of rosettes,
detachment of thymocytes from TDC, and staining
procedure are described in Materials and Methods.
Thymocytes were easily identified by appropri-
ate gating. The results presented in Fig. 3 and Table
1 show that TDC predominantly clustered with
CD4/CD8 and CD4/CD8 thymocytes. However, the
percentage of CD4/CD8 cells was lower, whereas
FIGURE 2. TDC rosettes stained with hematoxylin-eosin. TDC
rosettes were formed by incubating TDC and thymocytes (ratio
1:20) for 30 min at 37C as described in Materials and Methods.
Before staining rosettes were purified by brief centrifugation
(50 g for min at 4C) over FCS and incubated for 20 min on
PLL-coated glass slides to allow their better attachment and
spreading, followed by 0.1% glutar-aldehide fixation. Magnifi-
cation x320.
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FIGURE 3. Flow cytometric analysis of thymocyte subsets defined by the expression of CD4 and CD8 among total thymocytes (A)
and thymocytes bound toTDC in vitro (B). The formation of rosettes, detachment of thymocytes from TDC, and staining of thymocytes
with mAbs were as described in Materials and Methods. Thymocytes were analyzed on a FACScan flow cytometry by appropriate
gating. Representative profiles of CD4 and CD8 expression are given.40 MIODRAG (OLI( and VESNA ILI(
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FIGURE 4. Expression ofc3TCR on total thymocytes (solid line)
and thymocytes bound to TDC in vitro (dotted line). Thymocytes
were prepared and stained by R 73 mAb as described. The his-
tograms are representative of three experiments with similar re-
sults. The vertical bar represents the level of nonspecific stain-
ing using PBS and secondary antibody as control.
the percentage of CD4/CD8 cells was higher than
the values of these cells subsets in the whole
thymocyte population. The conclusion that thymo-
cytes bound to TDC were enriched in more mature
thymocytes was drawn by analyzing the fluores-
cence profile of thymocytes stained by an anti-
c[TCR antibody (R73). Figure 4 and Table 1 show
that among adherent thymocytes (compared to
whole thymocytes), a higher percentage of the
0TCR
hi subset was observed.
Effect of Bivalent Cations on Rosette Formation
between TDC and Thymocytes
The next experiments were designed to study the
mechanisms involved in TDC/thymocyte adhesion.
We first studied the effect of bivalent cations (Ca2+
and Mg2/) in the rosette formation after 30 min of
cell incubation at 37C. Figure 5 shows that Ca2+-
and Mg2/-free HBSS medium only partly suppressed
thymocyte binding to TDC. The separate addition
of Ca2+ and Mg
2/ ions to HBSS medium partly re-
stored thymocyte binding to TDC. If these cations
were added simultaneously, the percentage of ro-
settes did not significantly differ from the values
obtained using the classical medium (RPMI+10%
FCS).
The effect of Ca2+ and Mg
2+ chelators (EDTA and
EGTA) was also tested both at 37 and 4C. Figure 6
shows that these agents in a dose-dependent man-
ner (except at 4C, after 3 hr) suppressed rosette for-
mation. The percentage of inhibition was almost
equal independently of incubation temperature.
However, the inhibition decreased with prolonged
incubation (3 hr).
Signaling Pathways Involved in
TDC/Thymocyte Adhesion
Signaling pathways involved in the rosette for-
mation between TDC and thymocytes were stu-
died using various types of metabolic inhibitors.
Figure 7 shows that cytochalasin B (an inhibitor of
microfilament formation) partially decreased the
percentage of rosettes at 37C (30 min). Similar re-
sults were obtained after 3 hr of cell incubation (not
shown). As expected, cycloheximide (an inhibitor of
protein synthesis) did not influence the TDC/
thymocyte binding. We also treated TDC and
thymocytes with various protein kinases inhibitors
at 37C. H7 (a PKA and PKC inhibitor) and genistein
(a tyrosine kinase inhibitor) did not influence the
adhesion process. In contrast, W7 (specific inhibitor
of calmodulin-dependent protein kinase) was partly
inhibitory. Similar inhibition was seen after 3 hr (not
shown). The adhesion was not modified by using
TABLE
Phenotype of Rat Thymocytes Bound to TDC
Phenotype Total thymocytes (%) Bound thymocytes (%)
CD4-CD8- 2.1+0.5 2.1+1.2
CD4/CD8 83.8+3.6 75.7+5.6
CD4/CD8- 9.2+0.6 17.5+2.6
CD4-CD8 4.7+2.8 4.7+2.5
(/TCR low/interm. 52.2+6.1 48.3+4.1
high 12.0+3.2 23.5+3.6
aThe formation of rosettes, detachment of thymocytes from TDC, and staining of thymocytes with mAbs described in Materials and Methods.
Thymocytes analyzed FACScan flow cytometer by appropriate gating. Values (mean SD from different experiments) given percentages
of particular thymocyte subset.
bp 0.001 compared to corresponding values of total thymocytes.THYMIC DENDRITIC CELL/THYMOCYTE ADHESION 41.
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FIGURE 5. Effect of bivalent cations on thymocyte binding to TDC. Thymocytes were mixed with TDC in different media. Ca2+
and Mg were used at concentration of 5 mM. Cells were incubated for 30 min at 37C. The results are presented as the mean
percentages of rosettes + SD from 3 different experiments.
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FIGURE 6. Effect of bivalent cation chelators (EGTA + EDTA) on thymocyte binding to TDC. Thymocytes and TDC were incu-
bated in RPMI/10% FCS at 4 or 37C for 30 min or 3 hr. EDTA and EGTA were added at concentrations of 1-10 mM. The results
are presented as mean of rosette percentages + SD from 3 different experiments.42 MIODRAG OLId and VESNA ILI(
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FIGURE 7. Effect of various metabolic and cell-signaling inhibitors on thymocyte binding to TDC. TDC and thymocytes were
preincubated with different inhibitors for 30 min at 37C before mixing as described. Cells were then incubated with inhibitors for
additional 30 min at 37C. The results are presented as the mean percentages of rosettes + SD from 3 different experiments. p
< 0.001 compared to control (RPMI/10% FCS medium).THYMIC DENDRITIC CELL/THYMOCYTE ADHESION 43
sodium orthovanadate (an inhibitor of protein
phosphotyrosine phosphatases).
Surface Cell Molecules Involved in TDC/
Thymocyte Binding
The final aim of this work was to examine the role
of cell-surface molecules in TDC/thymocytes adhe-
sion by using mAbs directed to several rat adhesion
molecules. Figure 8 shows the effect of mAbs to [32
integrins, ICAM-1, and CD2 on TDC/thymocyte
binding. The results demonstrated that of the mAbs,
WT.1 (anti-LFA-1), WT.3 (anti-CD18), and 1A29 (anti-
ICAM-1) mAbs were partly inhibitory after 30 min.
WT-3 had the strongest effect (approx. 55% inhibi-
tion) that was not further potentiated using combi-
nation of WT.1 and WT.3. Figure 8 also shows that
inhibitory effects of WT.1 and WT.3 were lesser
after 3 hr of cell incubation. At that time, point 1A29
was not inhibitory. The mAbs to CD11b (ED7) or
CD11b/c (OX-42) as well as CD2 (OX-34) did not
significantly modify the adhesion. The inhibitory
effect of OX-34 mAb on TDC/thymocyte adhesion
was also not seen under condition when the main
pathway (LFA-1/CD18) was blocked using a com-
bination of WT.1, WT.3, and OX-34 mAbs.
A lot of mAbs stimulated TDC/thymocyte bind-
ing. They were OX-3 and OX-6 (both directed to class
IIMHC molecules), R73 (anti-0[3TCR), W3/25 (anti-
CD4), OX-8 (anti-CD8), and G3C5 (anti-CD45 frame-
work) antibody (Fig. 9). The gtimulated adhesion was
not only manifested by an increase in the percent-
age of rosettes, but also by a significant enlargement
of their sizes.
The stimulatory effect of anti-0[3TCR, anti-CD4,
and anti-CD8 was visible during the first adhesion
phase (30 min), whereas the effect of OX-3 and OX-
6 mAbs was observed after 3 hr of cell incubation.
G3C5 mAb stimulated TDC/thymocyte binding in
both adhesion phases. OX-18 mAb, directed to class
I MHC, was without significant effect in this proc-
ess. We further tested whether stimulatory effects of
these mAbs were mediated by LFA-1. The results
presented in Fig. 9 show that, except for G3C5,
preincubation of thymocytes with WT. 1 abrogated
the stimulated adhesion of all these mAbs.
DISCUSSION
This work was designed to study the mechanisms
involved in the adhesion between TDC and
thymocytes. We started the experiments using a
modification of the procedure for isolation of rat
TDC. It involved selective centrifugation of whole
thymocyte suspension over a Nycodenz gradient
(14.5%, osmolarity 390 mOsm) and further cultiva-
tion of low-density cells (TDC purity about 30%) for
3 days in medium supplemented with the TE-R 2.5
+ HT supernatant. This supernatant was prepared
by cocultivation of a rat medullary thymic epithelial
cell line (TE-R 2.5) (olid et al., 1992) with hydro-
cortisone-resistant thymocytes. Cytokines and other
soluble factors derived from these cells promoted
significant survival of TDC in culture and their
morphological and phenotypical differentiation to
the cells expressing most characteristics of TDC
in situ. At the same time, TDC purity significantly
increased (more than 80%) due to apoptosis of con-
taminating thymocytes and selective attachment of
thymic Mq) and monocytelike cells to plastic. All
these properties of TDC were presented in our
recent work (Ilid et al., in press).
Using such prepared cells, we found that rat
thymocytes strongly bound toTDC and formed large
clusters (rosettes). Attached thymocytes were en-
riched in the 0TCR
hi subset (predominantly
CD4+CD8-), but a large proportion of thymocytes
were phenotypically immature, CD4/CD8 cells.
Such an in vitro analysis of thymocyte phenotype has
not been performed. However, the results are simi-
lar to those of Shortman and Vremec (1991), who
analyzed by flow cytometry the phenotype of
thymocytes bound to mouse TDC, immediately
after in vivo isolation of the rosettes. They found
that the TDC rosettes were enriched in thymocytes
expressing high levels of surface TCR and CD3, and
these included both CD4+CD8-CD3 and CD4-
CD8/CD3 mature thymocytes. Both these and our
results are in agreement with the topographical
localization of TDC in situ (cortico-medullary zone
and medulla) in which final differentiation and
maturation processes of thymocytes occur (Barclay
and Mayrhofer, 1981; Hamblin and Edgeworth,
1988). The finding that CD4+CD8+czTCRw (imma-
ture phenotype) thymocytes showed a similar in-
cidence in total thymocyte pool as the population
isolated from TDC after binding, suggests that the
immature thymocytes in the cortex have already de-
veloped the potential to bind TDC that they may
encounter later on during their intrathyrnic sojourn.
Physiologically, thymocytes with this phenotype can
be localized in the cortico-medullary zone where
they may come into close contact with TDC. The44 MIODRAG OLId and VESNA ILId
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FIGURE 8. Effect of mAbs to rat adhesion molecules on thymocyte binding to TDC. Thymocytes and TDC were prepared as
described in Materials and Methods. Before mixing, thymocytes were preincubated for 30 min at 4C with mAbs WT.1, WT.3, OX-
34, combination of these mAbs or BH1 (an irrelevant [Ir] mAb) and TDC were preincubated with 1A29, ED7, OX-42 mAbs or BH1,
all at the concentrations of 10 gg/ml. Values (mean + SD from three to four different experiments) are given as percentage relative
binding to control (medium without mAb) (100% relative binding). p < 0.01; p < 0.001 compared to Ir mAb.THYMIC DENDRITIC CELL/THYMOCYTE ADHESION 45
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FIGURE 9. Effect of mAbs reactive with rat cell-surface antigens on thymocyte binding to TDC. Thymocytes and TDC were pre-
pared as described in Materials and Methods. Before mixing, thymocytes were preincubated for 30 min at4C with mAbs R 73, W3/
25, OX-8, G3C5, WT.1, IrmAbs (BH1 or BH2 mAb), or WT.1 in combination with these mAbs, and TDC were preincubated with OX-
3, OX-6, OX-18 mAbs, or BH1, all at the concentration of 10 tg/ml. Values (mean + SD from three to four different experiments)
are given as percentage relative binding to control (medium without mAb) (100% relative binding). p < 0.01; p < 0.001
compared to Ir mAb (BH1). Values for BH2 were almost the same as BH1 (data not shown).46 MIODRAG OLI( and VESNA ILI(
contact of TDC with CD4/CD8 is also possible in
the medulla. Using double immunofluorescence, we
found that 15-20% of thymocytes in the medulla of
AO rat thymus were CD4/CD8 (oliG unpublished
observation). Some immunohistological investiga-
tions also showed preferential contacts of CD4
T cells withDC in situ (Janossy et al., 1980), but more
precise dual immunolabeling was not performed to
demonstrate whether they are double (CD4/CD8/)
or single (CD4+CD8-) positive. We think that TDC
have different impact on distinct thymocyte sub-
sets (induction of apoptosis of CD4/CD8 cells;
stimulation of proliferation of CD4+CD8 cells).
This hypothesis is currently being tested in our
laboratory.
The main aspect of this work concerned the
mechanisms involved in the binding of thymocytes
to TDC. Such studies are scarce, but it is well known
that DC isolated from peripheral lymphoid tissues
efficiently cluster T cells, a phenomenon that is not
dependent on antigen-specific interaction, but rather
engagement of various adhesion molecules (Inaba
et al., 1989; King and Katz, 1989). Our findings in-
dicate that the LFA-1/ICAM-1 interaction plays a
key role in the early adhesion phase (30 min) be-
tween thymocytes and TDC, when the adhesion
process was maximal. Inhibitory effects of mAbs
against these molecules decreased after prolonged
incubation (3 hr). This is in accordance with pre-
vious studies in other cells systems showing the role
of the LFA-1 molecule in the stabilization of the early
rapid adhesion process (Dustin and Springer, 1989;
Lepesant et al., 1990). Scheeren et al. (1991) demon-
strated that clustering of human peripheral blood
DC with T lymphocytes was predominantly LFA-
1/ICAM-l-dependent. However, in contrast to our
results, the inhibitory effect of applied mAbs was
seen after 4 hr of cell incubation, at the time point
of maximal adhesion. The difference could be ex-
plained by different dynamics of cell adhesion
in these two systems, differences in T cells used
(thymocytes vs. peripheral T cells) and probably
different phenotypic and functional status of DC.
In our experiments, this adhesion pathway was
probably a consequence of the binding of LFA-1 ex-
pressed on thymocytes to ICAM-1 expressed on
TDC, but an engagement of LFA-1 on TDC with a
subset of thymocytes expressing ICAM-1 could be
also considered. Namely, in our previous studies,
we found that rat TDC express both LFA-1 and
ICAM-1 (Ilid et al., in press), whereas almost all
thymocytes and a subset of these cells (20%) are
LFA-1 and ICAM-I/, respectively (t2olid et al., 1994).
Our results also demonstrated that anti-LFA-1 and
anti-CD18 mAbs had stronger inhibitory effects than
anti-ICAM-1 mAb, suggesting that LFA-1/CD18
might use other ligands (ICAM-2 or ICAM-3)
(Staunton et al. 1989; Fawcett et al., 1992). How-
ever, little is known about their expression on TDC
and mAbs to these molecules in rat are not avail-
able. The importance of the LFA-1/ICAM-1 pathway
in our experiments was also documented by the
dependence of cell clustering upon CaR+ and Mg
2+
ions. It is well known that these cations are neces-
sary for 2 integrin function (Patarroyo et al., 1990;
Springer, 1990).
Significance of the LFA-1/ICAM-1 pathway in
thymocyte maturation is well documented because
mAbs to these molecules block the development of
DP thymocytes in fetal thymic organ culture (Fine
and Kruisbeek, 1991) and antigen-dependent dele-
tion of DP thymocytes from mice that are trans-
genic for class I MHC-restricted TCRs (Carlow
et al., 1992; Pircher et al., 1993). The latter findings
are of special interest because TDC are believed to
play a crucial role in negative selection (deletion of
autoreactive T cells in the thymus) (Ramsdell and
Fowlkes, 1990).
We demonstrated that TDC/thymocyte binding
was not completely blocked by anti-LFA-1, anti-
CD18, and anti-ICAM-1 mAbs, suggesting that other
adhesion molecules are involved.
MAbs against CD11b were not inhibitory, which
is in contrast with their effect on clustering between
peripheral ratDC and T lymphocytes (Damoiseaux,
1991) or thymocytes and thymic macrophages (M)
(olid et al., 1994). One possible explanation of the
phenomenon is a low expression of this [2 integrin
on TDC (Ili et al., in press). Scheeren et al. (1991)
also reported that adhesion between peripheral DC
and T cells was partly LFA-l-independent because
T cells from leukocyte adhesion deficiency (LAD),
which are defective in ]2 integrin expression, bound
to DC at low rates. We did not identify other adhe-
sion molecules because numerous mAbs against
different surface-cell molecules were not inhibitory.
It was important to stress that OX-34 (anti-CD2)mAb
used in this study as well as other anti-CD2 mAbs
(OX-54 and OX-55) (data not shown) did not inhibit
rosette formation, suggesting that the CD2/CD48
interaction (Killen et al., 1988) was not probably
operative under these experimental conditions. It
was demonstrated that the CD2/LFA-3 pathway is
not involved in T-cell/blood-DC (Scheeren et al.,
1991) binding, which is in contrast to the situation
of T-cell adhesion to tonsillar DC, where this path-THYMIC DENDRITIC CELL/THYMOCYTE ADHESION 47
way has been found to play a role (King and Katz,
1989).
A number of adhesion molecules has been iden-
tified on DC such as B7, B7-2, VCAM-1, CD44 (King
and Katz, 1989; Scheeren et al., 1991; Caux et al., 1994;
Inaba et al., 1994), but their role in binding of
thymocytes to TDC has not been studied. We found
that mAbs against CD4, CD8, {x3TCR, and class II
MHC molecules stimulated TDC/thymocyte adhe-
sion. The process was probably not a consequence
of a simple crosslinking of mAbs on cell surface
because the stimulated adhesion was not seen at4C
(not shown) and was inhibited by LFA-1 (Fig. 9).
In addition, an enhancement of clustering was also
observed when both TDC and thymocytes were
preincubated with saturated concentrations of the
mAbs before cell mixing (data not shown). It could
be postulated that under these conditions, both spe-
cific receptors and maybe Fc receptors on TDC (if
they exist) are occupied precluding the possibility
of crosslinking. Many mAbs, with different isotypes
(IgG1 or IgM), to rat cell-surface molecules that are
abundantly expressed on thymocytes, such as anti-
CD2 (Fig. 8) or anti-CD43 and OX-52 (not shown),
were not stimulatory. This is another argument
favoring the specificity of the observed phenomenon.
The stimulated adhesion could be explained by
previous results that showed that signaling through
TCR and coreceptor molecule triggered by specific
mAbs to these antigens increased affinity of LFA-1
for its ligand (Dustin and Springer, 1989; van Kooyk
et al., 1989). The effect was not a consequence of the
upregulation of the LFA-1 expression on cell surface,
but rather was a result of conformational changes of
the LFA-1 molecule.A similar effect ofmAbs to CD3,
CD4, and CD8 was observed in another system of
heterotypic cell adhesion using thymocytes and
thymic epithelial cell lines (Lepesant et al., 1990).
Certain mAb to class II MHC induced homotypic
aggregation of lymphocytes that was also partly
LFA-l-dependent (Kansas and Tedder, 1991).
Our preliminary results showed that all these
stimulatory antibodies modify intracellular signaling
pathways of thymocytes, but their effects on thymo-
cyte proliferation in the presence of TDC are not
the same. Namely, R73 stimulated thymocyte pro-
liferation, whereas the others were inhibitory. The
results are in agreement with those reported by
Xu et al. (1992), who did not show the correlation
between the intensity of human blood DC/T
lymphocyte clustering and proliferation rates of the
T cells.
In contrast to the previous mAbs, an anti-CD45
framework mAb (G3C5) stimulated the adhesion
via an LFA-l-independent pathway. This antibody,
which has been recently produced in our laboratory
(Pavlovid et al., manuscript in preparation), induces
strong homotyipic aggregation of rat leukocytes. It
was also found that certain anti-human CD45 mAbs
either increased the size of clusters in culture of DC
and human T lymphocytes (Xu et al., 1992) as well
as tonsillar T cells and U-937 cells (King et al., 1990)
or reduced cluster stability between DC and T
lymphocytes (Prickett and Hart, 1990). G3C5 is dif-
ferent from similar proaggregatory anti-CD45 mAbs
(Lorenz et al., 1993; Bernard et al., 1994) by its cap-
ability to induce the LFA-l-independent adhesion
of both resting and activated leukocytes and at
the same time to stimulate mitogen-induced T-
lymphocyte proliferation and allogeneic MLR. The
effect is probably epitop-specific and is not influ-
enced by isotype of the mAb (IgM) (Pavlovid et al.,
manuscript in preparation). The mechanisms in-
volved in the processes are currently investigated
Scheeren et al. (1991) also demonstrated that an anti-
CD44 mAb enhanced conjugate formation between
T cells and blood DC that could not be blocked by
anti-LFA-1 mAb.
Our results showed that an intact cytoskeleton and
the activity of calmodulin-dependent protein kinase
were partly responsible for TDC/thymocyte adhe-
sion because the process was blocked by cyto-
chalasin B and W7, respectively. This is in agreement
with the results published for blood DC/T-cell bind-
ing (Scheeren et al., 1991). We hypothesize that W7
inhibits cell adhesion by modulating cytoskeleton
integrity, because similar observations were pub-
lished in our recent study dealing with the LFA-1-
dependent homotypic aggregation of rat leukocytes
(Pavlovid et al., 1994).
Blood DC/T-cell adhesion was also partly blocked
by H7 (an inhibitor of PKA and PKC) (Scheeren
et al., 1991), which was not seen in our experiments.
We also found that neither inhibition of protein
tyrosine kinases by genistein nor inhibition of
protein tyrosine phosphatases by sodium ortho-
vanadate blocked rosette formation. These enzyme
inhibitors have not been tested in other similar cell
systems.
We also found that the kinetics of rosette forma-
tion differ between 4 and 37C. Both processes were
partly dependent on Ca
2/ andMg
2+ ions. At the same
time, anti-LFA-1/CD18 mAbs were without signifi-
cant effect at this temperature (data not shown). At
the moment, it is not clear whether this difference is
due to difference in binding characteristics and/or48 MIODRAGOLI and VESNA ILId
dependent on lower-cell motility at 4C. So this
phenomenon needs to be explored in more detail in
further experiments.
In conclusion, this work shows that thymocyte
adhesion to TDC is a complex and poorly under-
stood process and underlines some differences be-
tween our results and those published for T-cell
binding to peripheral DC. The differences could be
a consequence of specific functions of TDC in
thymocyte development, which are attractive for
further studies.
MATERIALS AND METHODS
Animals
AO rats, both sexes, 8 -10 weeks old, bred at the Farm
for Experimental Animals (MMA, Belgrade), were
used in this study.
MAbs and reagents
A large panel ofmAb was used (Table 2). G3C5 (anti-
CD45 framework) (IgM) (Pavlovid et al., manuscript
in preparation) was produced at the Institute of
Medical Research (MMA, Belgrade). Mabs WT.1
(anti-CD11a; IgG2a), WT.3 (anti-CD18; IgG1;
Tamatani et al., 1991a) and 1A29 (anti ICAM-1; IgG1;
Tamatani and Miyasaka 1990) were produced in
Tokyo. All these mAbs recognize "inhibitory" epi-
topes on the corresponding molecules (Tamatani
et al., 1991b). ED7 mAb (IgG1) reactive with rat
CD11b (Damoiseaux et al., 1989) was a gift from
Dr. C. Dijkstra (Amsterdam) and R73 (anti-013TCR;
IgG1; Hunig et al., 1989) was a gift from Dr. T. Hunig
(Wurzburg). OX-18 (anti-class I MHC molecule;
IgG1), OX-3 (anti-class IIMHC molecule; IgG1), OX-
6 (anti-class II MHC molecule; IgG1), OX-42 (anti-
CD11b/c; IgG2a), OX-34 (anti-CD2; IgG1), W3/25
(anti-CD4; IgG1), and OX-8 (anti-CD8; IgG1) were
obtained from Serotec (UK). For flow cytometric
analysis, anti-CD-FITC (Serotec) was used.
The metabolic inhibitors used in this work were
Genistein, an inhibitor of tyrosine kinases; H7, an
inhibitor of PKA and PKC; W7, an inhibitor of
calmodulin-dependent protein kinase; sodium or-
thovanadate, an inhibitor of phosphotyrosine pro-
tein phosphatases; cytochalasin B, an inhibitor of
microfilament formation; and cycloheximide, an
inhibitor of protein synthesis. All chemicals were
obtained from Sigma (USA). Their concentrations
used in the experiments were nontoxic for cells,
studied by tripan blue dye exclusion.
Isolation of TDC
Thymic-cell suspension was obtained by teasing
thymuses against a steel mesh. Released cells were
collected and resuspended in RPMI-1640 medium
(Serva, Munich) containing 10% fetal calf serum
(FCS) (Flow, Irving, Scotland), 2 mM 1-glutamine,
and 1% gentamycin with addition of 0.04% EDTA to
dissociate thymic clusters. The cell suspension was
filtered through a nylon gauze to remove fibrous
residue. To enrich this suspension for TDC, the cells
resuspended in the same medium (2 x 108 cells/3 ml)
were layered above 3 ml of Nycodenz gradient (den-
sity 1.078 g/cm and osmolarity 390 mOsm) and cen-
trifuged at 600 g for 15 min at room temperature.
Cells from the interface zone were collected, washed
twice, adjusted at 2.5 x 10 cells/ml and cultivated
for 3 days in RPMI/10% FCS medium with addition
of 20% TE-R 2.5 + HT supernatant (24-well, flat
bottom plates; Flow) in an incubator with 5% CO2.
The TE-R 2.5 + HT supernatant was prepared by
cocultivating a confluent monolayer of a rat thymic
medullary epithelial cell line TE-R 2.5 (olid et al.,
1992) and hydrocortisone-resistant thymocytes as
described (Ili4 et al., in press). After this culture
period, TDC became nonadherent and formed large
clusters. Contaminating McI) became adherent
whereas most thymocytes died. Nonadherent cells
TABLE 2
Characteristics of Monoclonal Antibodies Used in This Study
mAb sotype Specificity Source
OX-3 IgG1 MHC class II A
OX-6 IgG1 MHC class II A
OX-18 IgG1 MHC class A
G3C5 IgM CD45 B
1A29 IgG1 CD54 C
WT.1 IgG2a CD11a C
WT.3 IgG1 CD18 C
ED7 IgG1 CD11b D
OX-42 IgG2a CD11b/c A
OX-34 IgG1 CD2 A
W3/25 IgG1 CD4 A
OX-8 IgG1 CD8 A
R 73 IgG1 (xTCR E
A. mAb obtained commercially from Serotec (UK). B. mAb pro-
duced at the Institute of Medical Research, MMA (Belgrade)
(Pavlovic et al., manuscript in preparation). C. mAb obtained
from Dr. M. Miyasaka, Tokyo (Tamatani and Miyasaka, 1990)
and (Tamatani et al., 1991a)b. D. mAb obtained from Dr. C.
Dijkstra,Amsterdam (Damoiseaux et al., 1989). E. mAb obtained
from Dr. T. Hunig (Wurzburg) (Hunig et al., 1989).THYMIC DENDRITIC CELL/THYMOCYTE ADHESION 49
were collected, resuspended in RPMI/10% FCS
medium with 0.04% EDTA, to dissociate clusters, and
purified again over a Nycodenz gradient as de-
scribed before. The purity of such preparedTDC was
usually more than 80%.
For statistical analysis (Student test), the percent-
age of relative binding in the presence of specific
mAb was compared with that using isotype corre-
sponding to irrelevant mAb.
Rosette Assay for TDC-Thymocyte Binding
Cultivated TDC (1 x 104) were mixed with 2 x 105
thymocytes (ratio 1:20) in 20 tl of RPMI/10% FCS
medium in Terasaki microwell plates and then cul-
tivated in hanging drops at 4 or 37C for various
periods of time. The cells were observed under a light
microscope. TDC that bound 4 or more thymocytes
were scored as rosettes. For each assay, 200TDC were
counted and each determination was performed in
duplicate. The results are given as the mean percent-
age of rosettes.
For experiments in which we studied signaling
pathways involved in rosette formation TDC and
thymocytes were preincubated for 30 min at 37C
in RPMI/10% FCS medium with the addition of
cytochalasin B (1-10 tg/ml), cycloheximide (10 tg/
ml), genistein (50 tg/ml), H7 (80 tM), W7 (10-
30 tM), or sodium orthovanadate (100 tM). For sta-
tistical analysis (Student test), the percentage of
rosettes formed in the presence of a specific inhibi-
tor was compared with that formed in RPMI/10%
FCS medium.
For experiments in which we studied effects of
bivalent cations on rosette formation TDC and
thymocytes were washed in HBSS medium without
Ca2+ and Mg
2+ and then incubated in HBSS medium
with the addition of 5 mM CaC12 (Serva or 5mM
MgC12 (Serva), or with the simultaneous addition of
5 mM CaC12 and 5 mM MgC12.
For blocking experiments,TDC were preincubated
with OX-3, OX-6, OX-18, 1A29, ED7, or OX-42 mAb,
and thymocytes were preincubated with WT.1, WT.3,
OX-34, R73, W3/25, OX-8, or G3C5 mAb at 4C
for 30 min. Both TDC and thymocytes were pre-
incubated with irrelevant mAbs BH1 (IgG1) or
BH2 (IgM), both against Blastocystis hominis, pro-
duced at the Institute of Medical Research (MMA,
Belgrade). All antibodies were continuously present
during the assay. The results are presented as
% Relative binding
number of rosettes
with mAb
number of rosettes
without mAb
x 100
Flow Cytometry
TDC rosettes formed at 37C after 45 min were lay-
ered over 3 ml of FCS and centrifuged at 50 g for
1 min at 4C. Single cells from the upper layer and
the interface zone were discarded. Cell clusters in
the sediment were washed and resuspended in PBS
with 2% FCS, 0.1% sodium azide, and 0.04% EDTA.
This treatment dissociates thymocytes from TDC.
Thymocytes were then adjusted at concentration of
2 x 105 cells/tube and incubated with mAbs diluted
in PBS with 2% FCS, 0.1% sodium azide, and 0.04%
EDTA for 45 min at 4C.
Single staining was performed using R73 (anti-
cTCR) mAb followed by a sheep anti-mouse Ig an-
tibody .conjugated with FITC (INEP, Zemun, YU).
Two-color staining for CD4 and CD8 expression on
thymocytes was performed by sequential incubation
of the cells with OX-8 mAb, biotin-conjugated mouse
anti-rat IgG1 (Serotec), streptavidin-PE (Serotec), and
anti-CD4-FITC mAb. All antibodies were diluted in
PBS with 2% FCS, 0.1% sodium azide, and 0.04%
EDTA.
Stained cells were fixed in 4% formalin and
analyzed on a FACScan flow cytometer (Becton
Dickinson). TDC were excluded by appropriate
gating on the basis of forward scatter vs. side angle
scatter profile. Expression of0TCR is displayed as
histograms of green fluorescence (log) vs. number
of (5 X 103) cells. Results of two-color staining are
displayed as histograms of green fluorescence (log)
vs. red fluorescence (log).
Background fluorescence was determined with an
irrelevant isotype-specific mousemAb or secondary
antibody only.
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